BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12408227)

  • 1. Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells.
    Liu W; Asa SL; Ezzat S
    Brain Pathol; 2002 Oct; 12(4):412-9. PubMed ID: 12408227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.
    Liu W; Asa SL; Fantus IG; Walfish PG; Ezzat S
    Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
    Park WH; Seol JG; Kim ES; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY
    Exp Cell Res; 2000 Feb; 254(2):279-86. PubMed ID: 10640426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
    Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
    Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells.
    Wu G; Fan RS; Li W; Ko TC; Brattain MG
    Oncogene; 1997 Sep; 15(13):1555-63. PubMed ID: 9380407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
    Lin R; Wang TT; Miller WH; White JH
    Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells.
    Eguchi H; Herschenhous N; Kuzushita N; Moss SF
    Cancer Res; 2003 Aug; 63(15):4739-46. PubMed ID: 12907657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.
    Nguyen H; Gitig DM; Koff A
    Mol Cell Biol; 1999 Feb; 19(2):1190-201. PubMed ID: 9891053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
    Zhang F; Mönkkönen M; Roth S; Laiho M
    Exp Cell Res; 2002 Dec; 281(2):190-6. PubMed ID: 12460649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
    Zhu X; Kwon CH; Schlosshauer PW; Ellenson LH; Baker SJ
    Cancer Res; 2001 Jun; 61(11):4569-75. PubMed ID: 11389092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.
    Hara T; Kamura T; Nakayama K; Oshikawa K; Hatakeyama S; Nakayama K
    J Biol Chem; 2001 Dec; 276(52):48937-43. PubMed ID: 11682478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase.
    Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W
    J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX3-FKHR transformation increases 26 S proteasome-dependent degradation of p27Kip1, a potential role for elevated Skp2 expression.
    Zhang L; Wang C
    J Biol Chem; 2003 Jan; 278(1):27-36. PubMed ID: 12401804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p42/p44 mitogen-activated protein kinase activation triggers p27Kip1 degradation independently of CDK2/cyclin E in NIH 3T3 cells.
    Delmas C; Manenti S; Boudjelal A; Peyssonnaux C; Eychène A; Darbon JM
    J Biol Chem; 2001 Sep; 276(37):34958-65. PubMed ID: 11418594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
    Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
    Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein.
    Ryhänen S; Jääskeläinen T; Mahonen A; Mäenpää PH
    Biochem Pharmacol; 2003 Aug; 66(3):495-504. PubMed ID: 12907249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.